Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 16

1.

HCV genotype 1a shows a better virological response to antiviral therapy than HCV genotype 1b.

Pellicelli AM, Romano M, Stroffolini T, Mazzoni E, Mecenate F, Monarca R, Picardi A, Bonaventura ME, Mastropietro C, Vignally P, Andreoli A, Marignani M, D'Ambrosio C, Miglioresi L, Nosotti L, Mitidieri O, Gentilucci UV, Puoti C, Barbaro G, Barlattani A, Furlan C, Barbarini G; CLEO Group.

BMC Gastroenterol. 2012 Nov 16;12:162. doi: 10.1186/1471-230X-12-162.

2.

Peginterferon and ribavirin treatment for hepatitis C virus infection.

Tsubota A, Fujise K, Namiki Y, Tada N.

World J Gastroenterol. 2011 Jan 28;17(4):419-32. doi: 10.3748/wjg.v17.i4.419. Review.

3.

Effect of spleen operation on antiviral treatment in hepatitis C virus-related cirrhotic patients.

Feng B, Zhang W, Luo BF, Song GJ, Wang J, Jin Q, Qin H, Wei L.

World J Gastroenterol. 2014 Nov 7;20(41):15387-97. doi: 10.3748/wjg.v20.i41.15387. Review.

4.

Is the benefit of treating patients with cirrhosis proven?

Bruno S, Boccaccio V, Russo ML, Maisonneuve P.

Liver Int. 2016 Jan;36 Suppl 1:21-7. doi: 10.1111/liv.13013. Review.

PMID:
26725893
5.

Chronic hepatitis C genotype 1 treatment roadmap for resource constrained settings.

Lim SG.

World J Gastroenterol. 2015 Feb 14;21(6):1972-81. doi: 10.3748/wjg.v21.i6.1972. Review.

6.

Follow-up of patients with chronic hepatitis C and a sustained viral response.

Serfaty L.

Liver Int. 2016 Jan;36 Suppl 1:67-71. doi: 10.1111/liv.13016. Review.

PMID:
26725900
7.

Why I do not treat patients for mild disease.

Hézode C.

Liver Int. 2016 Jan;36 Suppl 1:13-20. doi: 10.1111/liv.13019. Review.

PMID:
26725892
8.

Can zinc enhance response interferon therapy for patients with HCV-related liver disease?

Ishikawa T.

World J Gastroenterol. 2012 Jul 7;18(25):3196-200. doi: 10.3748/wjg.v18.i25.3196. Review.

9.

Why do I treat my patients with mild hepatitis C?

Calvaruso V, Craxì A.

Liver Int. 2016 Jan;36 Suppl 1:7-12. doi: 10.1111/liv.13011. Review.

PMID:
26725891
10.

Indian National Association for Study of the Liver (INASL) Guidance for Antiviral Therapy Against HCV Infection in 2015.

Puri P, Anand AC, Saraswat VA, Acharya SK, Dhiman RK, Sarin SK, Singh SP, Chawla YK, Aggarwal R, Amarapurkar D, Arora A, Dixit VK, Sood A, Shah S, Duseja A, Kapoor D, Shalimar, Madan K, Pande G, Nagral A, Kar P, Koshy A, Puri AS, Eapen CE, Thareja S.

J Clin Exp Hepatol. 2015 Sep;5(3):221-38. doi: 10.1016/j.jceh.2015.09.002. Epub 2015 Sep 21. Review.

11.

Chronic hepatitis C treatment outcomes in low- and middle-income countries: a systematic review and meta-analysis.

Ford N, Kirby C, Singh K, Mills EJ, Cooke G, Kamarulzaman A, duCros P.

Bull World Health Organ. 2012 Jul 1;90(7):540-50. doi: 10.2471/BLT.11.097147. Epub 2012 Feb 3. Review.

12.

Consensus Statement of HCV Task Force of the Indian National Association for Study of the Liver (INASL). Part II: INASL Recommendations for Management of HCV in India.

Puri P, Anand AC, Saraswat VA, Acharya SK, Sarin SK, Dhiman RK, Aggarwal R, Singh SP, Amarapurkar D, Arora A, Chhabra M, Chetri K, Choudhuri G, Dixit VK, Duseja A, Jain AK, Kapoor D, Kar P, Koshy A, Kumar A, Madan K, Misra SP, Prasad MV, Nagral A, Puri AS, Jeyamani R, Saigal S, Shah S, Sharma PK, Sood A, Thareja S, Wadhawan M.

J Clin Exp Hepatol. 2014 Jun;4(2):117-40. doi: 10.1016/j.jceh.2014.06.001. Epub 2014 Jun 24. Review.

13.

Molecular diagnostics in the management of chronic hepatitis C: key considerations in the era of new antiviral therapies.

Cobb B, Heilek G, Vilchez RA.

BMC Infect Dis. 2014;14 Suppl 5:S8. doi: 10.1186/1471-2334-14-S5-S8. Epub 2014 Sep 5. Review.

14.

Hepatitis C genotype 6: A concise review and response-guided therapy proposal.

Bunchorntavakul C, Chavalitdhamrong D, Tanwandee T.

World J Hepatol. 2013 Sep 27;5(9):496-504. doi: 10.4254/wjh.v5.i9.496. Review.

15.

Advances in the Diagnosis and Monitoring of Hepatitis C Virus Infection.

Ciotti M, D'Agostini C, Marrone A.

Gastroenterology Res. 2013 Oct;6(5):161-170. Epub 2013 Oct 31. Review.

16.

HCV Council--critical appraisal of data: recommendations for clinical practice in a rapidly evolving therapeutic landscape.

Reau N, Fried MW, Nelson DR, Brown RS Jr, Everson GT, Gordon SC, Jacobson IM, Lim JK, Pockros PJ, Reddy KR, Sherman KE.

Liver Int. 2016 Apr;36(4):488-502. doi: 10.1111/liv.12993. Epub 2015 Nov 22. Review.

Supplemental Content

Support Center